Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07113288 · ClinicalTrials.gov registry record

Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study

A clinical trial of Obstructive Sleep Apnea (OSA), sponsored by Inspire Medical Systems.

Recruiting
Registry status
70
Enrollment target
5
Study locations

NCT07113288 is a study of Obstructive Sleep Apnea (OSA) that is actively recruiting participants, run by Inspire Medical Systems. The registered enrollment target is 70 participants, below the 586-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (88% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07113288, a study of Obstructive Sleep Apnea (OSA), is actively recruiting participants, sponsored by Inspire Medical Systems.

RECRUITING
Registry status
70 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this observational clinical study is to provide evaluation of long-term safety and effectiveness in a newly expanded patient population including patients with a higher AHI and a higher BMI.

Interventions

  • DEVICE Inspire® UAS System

Study Locations (5)

Colorado

  • Colorado ENT & Allergy - Colorado Springs

Florida

  • Florida Sleep Specialists - Bradenton

Illinois

  • Rush University Medical Center - Chicago

Kansas

  • University of Kansas Medical Center - Kansas City

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-07-31
Est. Completion 2032-01-01

Sponsor

Inspire Medical Systems

8 total trials

What the Registry Record Tells You About NCT07113288

The ClinicalTrials.gov registry entry for NCT07113288 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 586-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (88% lower). The listed sponsor is Inspire Medical Systems, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea (OSA) appearing as the primary indexed condition, and to 1 intervention - of which Inspire® UAS System is the first listed.

NCT07113288 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Colorado, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT07113288 about?

NCT07113288 is a clinical study titled "Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study". The purpose of this observational clinical study is to provide evaluation of long-term safety and effectiveness in a newly expanded patient population including patients with a higher AHI and a higher BMI.

What is the current status of trial NCT07113288?

This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2025-07-31. Estimated completion is 2032-01-01.

What conditions does trial NCT07113288 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea (OSA).

What interventions are being tested in trial NCT07113288?

The interventions under investigation include: Inspire® UAS System (DEVICE).

Who is sponsoring clinical trial NCT07113288?

This trial is sponsored by Inspire Medical Systems, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07113288 being conducted?

This trial has 5 study locations across Colorado, Florida, Illinois, Kansas, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea (OSA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.